Karin Eastham's Net Worth

$21.9 Million

Estimate Recalculated Nov 8, 2024 04:34PM EST

Who is Karin Eastham?

Karin Eastham has an estimated net worth of $21.9 Million. This is based on reported shares across multiple companies, which include ILLUMINA INC, SGX PHARMACEUTICALS, INC., TERCICA INC, GERON CORP, Trius Therapeutics Inc, VERACYTE, INC., GENOPTIX INC, NEKTAR THERAPEUTICS, Personalis, Inc., AMYLIN PHARMACEUTICALS INC, and DIVERSA CORP.

SEC CIK

Karin Eastham's CIK is 0001231845

Past Insider Trading and Trends

2011 was Karin Eastham's most active year for acquiring shares with 15 total transactions. Karin Eastham's most active month to acquire stocks was the month of April. 2004 was Karin Eastham's most active year for disposing of shares, totalling 38 transactions. Karin Eastham's most active month to dispose stocks was the month of December. 2017 saw Karin Eastham paying a total of $817,128.00 for 73,105 shares, this is the most they've acquired in one year. In 2017 Karin Eastham cashed out on 22,741 shares for a total of $2,306,690.49, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ILLUMINA INC (ILMN) Snapshot price: $125

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.74%
-789.00
$308.97
-$181,983.33
20.3K
Jan 22 - May 23
Form 4
-15.59%
-2.00K
$182.58
-$1,186,021.31
10.84K
Scheduled
Nov 6 - Jan 2
Form 4
+4.48%
551
$270.80
-$249,677.60
12.84K
May 22 - May 23
Form 4
-7.53%
-1.00K
$269.80
-$269,802.20
12.29K
Scheduled
May 21
Form 4
—
0
$150.23
-$316,555.42
13.29K
Scheduled
Mar 5
Form 4
-2.21%
-300.00
$135.33
-$1,288,872.00
13.29K
Scheduled
Jun 7 - Aug 2
Form 4
+20.43%
2.31K
—
—
13.59K
May 30
Form 4
-9.18%
-1.14K
$175.89
-$200,690.49
11.28K
May 18
Form 4
—
0
$90.82
-$545,300.30
12.42K
Scheduled
Jun 1
Form 4
+20.21%
2.09K
$138.77
-$106,020.28
12.42K
May 17 - May 18
Form 4
—
0
$120.14
-$650,375.00
10.42K
Scheduled
Sep 8
Form 4
—
0
$122.51
-$830,515.77
22.52K
Scheduled
Jun 1
Form 4
+9.37%
893
$205.09
-$208,576.53
10.42K
May 26 - May 27
Form 4
-2.06%
-200.00
$118.35
-$1,488,522.91
9.53K
Scheduled
Feb 2
Form 4
—
0
$110.96
-$1,493,350.55
9.73K
Scheduled
Jan 2
Form 4
—
0
$117.35
-$1,490,524.98
9.73K
Scheduled
Dec 4
Form 4
-1.02%
-100.00
—
—
9.73K
Jul 28
Form 4
—
0
$87.57
-$839,887.36
9.83K
Scheduled
Jun 2
Form 4
+18.61%
1.54K
$159.70
-$159,700.00
9.83K
May 27 - May 28
Form 4
—
0
$74.32
-$703,488.47
8.28K
Scheduled
Jan 2
Form 4
—
0
$56.29
-$774,175.06
8.28K
Scheduled
Nov 1
Form 4
—
0
$41.82
-$570,398.36
8.28K
Scheduled
Jun 3
Form 4
+43.22%
2.5K
—
—
8.28K
May 29
Form 4
-9.06%
-576.00
$56.33
-$32,446.08
5.78K
Apr 18
Form 4
—
0
$25.50
-$328,818.60
6.36K
Scheduled
Jun 1
Form 4
+29.27%
1.44K
—
—
6.36K
Apr 18
Form 4
—
0
$39.33
-$661,966.40
4.92K
Scheduled
Jun 1
Form 4
+17.14%
720
$73.27
-$52,754.40
4.92K
May 9 - May 10
Form 4
—
0
$39.67
-$282,288.13
4.2K
Scheduled
Mar 17
Form 4
—
0
$22.35
-$395,410.00
4.2K
Scheduled
Jun 1
Form 4
+31.25%
1K
$41.89
-$33,512.00
4.2K
May 10 - May 12
Form 4
—
0
$20.20
-$352,400.00
3.2K
Jun 1
Form 4
+60.00%
1.2K
$36.43
-$29,144.00
3.2K
May 7 - May 8
Form 4
—
0
$42.09
-$738,810.00
1K
Jun 2
Form 4
∞
1K
—
—
1K
May 16
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jul 30
Form 3
—
0
—
—
0
No matching records found

SGX PHARMACEUTICALS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-12.50K
$3.00
-$37,500.00
0
Aug 20
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 17
Form 3
—
0
—
—
0
No matching records found

TERCICA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-13.33K
$9.00
-$119,997.00
0
Oct 16
Form 4
+33.33%
3.33K
—
—
13.33K
May 20
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found

GERON CORP (GERN) Snapshot price: $4.29

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.27%
35K
$1.10
$38,500.00
109.05K
Jan 13
Form 4
—
0
—
—
0
May 10
Form 4
+89.64%
35K
$1.41
$49,350.00
74.05K
Apr 20
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 9
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 18
Form 4
+16.66%
5.58K
—
—
39.05K
Dec 31
Form 4
+10.37%
3.15K
—
—
33.47K
Jun 30
Form 4
—
0
—
—
0
May 20
Form 4
+14.43%
3.82K
—
—
30.32K
Dec 31
Form 4
-62.94%
-45.00K
—
—
26.5K
Jul 9
Form 4
—
0
—
—
0
May 22
Form 4
-3.38%
-2.50K
—
—
71.5K
Dec 31
Form 4
—
0
—
—
0
May 17
Form 4
+7.25%
5K
—
—
74K
May 20
Form 4
+15.00%
9K
—
—
69K
May 11
Form 4
+300.00%
45K
—
—
60K
Jul 9
Form 4
+100.00%
7.5K
—
—
15K
May 19
Form 4
∞
7.5K
—
—
7.5K
May 29
Form 3
—
0
—
—
0
No matching records found

Trius Therapeutics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-18.11K
—
—
0
Sep 11
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
May 22
Form 4
+49.53%
6K
$3.50
$21,000.00
18.11K
Mar 27
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Nov 3
Form 4
∞
12.11K
$4.38
$53,059.32
12.11K
Aug 6
Form 3
—
0
—
—
0
No matching records found